Malignant Head and Neck Neoplasm — Trials

Malignant Head and Neck Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

5,447 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,430
Recruiting: 778
Ph III recruiting: 109
Growth YoY: +19.8%
Industry share: 18%
Top sponsor: Sun Yat-sen University
Termination share: 29.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (629)

clinicaltrialsPublishedShowing 51–100 of 433 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05054439	A Clinical Study of SI-B001 in Combination With Paclitaxel/Docetaxel in the Treatment of Recurrent and Metastatic HNSCC	active not recruiting	Phase 2	45	Sichuan Baili Pharmaceutical Co., Ltd.INDUSTRY	1	Sep 1, 2026	clinicaltrials
NCT05355701	A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.	active not recruiting	Phase 1	103	PfizerINDUSTRY	3	Sep 1, 2026	clinicaltrials